50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today BIOL ranks #12517 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

$0.45 (-3.85%)

Volume: 2M

Closed: Nov 26, 2021

Hollow Logo Score: -4.887

Biolase Stock Forecast

$0.45 (-3.85%)

Volume: 2M

Closed: Nov 26, 2021

Score Hollow Logo -4.887
Which way will BIOL go? Request
Key Stats
P/E Ratio -3.95
Beta 1.78
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 80 ] The Biolase stock currently holds an RSI14 at 21 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Biolase stock price ended on $0.45 on Friday after losing 3.85%
(Updated on Nov 26, 2021)


Sell candidate since 2021-11-10 Loss -24.68%

The Biolase stock price fell by -3.85% on the last day (Friday, 26th Nov 2021) from $0.47 to $0.45. During the day the stock fluctuated 6.16% from a day low at $0.43 to a day high of $0.46. The price has fallen in 9 of the last 10 days and is down by -19.95% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -16 million shares and in total, 2 million shares were bought and sold for approximately $1.10 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -30.81% during the next 3 months and, with a 90% probability hold a price between $0.29 and $0.39 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, November 23, 2021, and so far it has risen 7.60%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biolase stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.56. On a fall, the stock will find some support from the short-term average at $0.45. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss

Biolase finds support from accumulated volume at $0.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0265 between high and low, or 6.16%. For the last week the stock has had a daily average volatility of 8.92%.

Biolase is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Biolase stock A Buy?

Biolase holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -4.887

Predicted Opening Price for Biolase of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$0.45 $0.45 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Aug 19, 2021 "Ascendiant Capital Markets" gave "$2.00 - $3.00" rating for BIOL. The price target was changed from $0.66 to 1.3%.

Volatility and Risk
Daily Average Volatility: 8.92 %
Overall Risk: Very High High Medium Low Very Low
Volatility
8.92 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $0.47
Price: $0.45
Support: $0.45

BIOL Insider Trading Show all Trades

INSIDER POWER

1.457

Last 100 transactions
Buy: 11 021 108 | Sell: 7 564 991 (Shares)
Date Action Amount Person Type
Aug 20, 2021 Buy 35 000 Beaver John R Common Stock
Aug 12, 2021 Buy 98 955 Oloughlin Kathleen T Stock Appreciation Right
Aug 12, 2021 Buy 98 955 Summerhays Carol Gomez Dds Stock Appreciation Right
Aug 12, 2021 Buy 98 955 Somerman Martha J. Dds, Phd Stock Appreciation Right
Aug 11, 2021 Buy 220 000 Beaver John R Stock Appreciation Right
Show all Insider Trades
INSIDER POWER

1.457

Last 100 transactions
Buy: 11 021 108 | Sell: 7 564 991 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.47 4.59 %
0.46 2.35 %
0.46 0.96 %
Current price: 0.45
Support 0.44 -3.52 %
0.43 -4.90 %
0.42 -7.14 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.56 24.92 %
0.50 11.09 %
0.47 4.01 %
Current price 0.45
Support 0.45 -0.0221%
0.45 -0.97%
0.42 -7.06%

Click to get the best stock tips daily for free!

About Biolase

Biolase BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons, a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT